Introduction
bodies by overnight fasting compared to wild type animals (13) . These facts suggest the possibility that ACCβ might also control fatty acid oxidation in liver and the regulation of its activities might be different in liver and muscle.
Most of the lipogenic enzymes, including ACCα, fatty acid synthase, stearoyl-CoA desaturase-1, and ATP citrate-lyase, are regulated by dietary regimen and insulin at transcription level in liver. These regulations are known to be mediated by SREBP-1 which is a member of the basic helix-loop-helix/leucine zipper family of transcription factors (14) (15) (16) (17) (18) . SREBP-1 has been identified as two isoforms (SREBP-1a and -1c) derived from a single gene through the use of alternative transcription start sites and splicing (19) . The precursors of SREBPs (~125 kDa) are located in endoplasmic reticulum. Upon activation, SREBPs are released from the membrane by a sequential two-step cleavage process and translocated into the nucleus as a mature protein (~68 kDa) (20) . SREBP-1c is a primary regulator in liver and adipose tissues, which mediates the activation of gene transcription by insulin and food intake (21) (22) (23) , while SREBP-1a is major isoform in established cell lines.
In the present study, we first demonstrate that ACCβ gene transcription driven by promoter II is induced in liver by the intake of high-carbohydrate diet. Moreover, the nuclear form of SREBP-1 activates ACCβ promoter II by its binding to SREs and food intake increases the occupancy of SREBP-1c in ACCβ promoter II in liver.
Lipofectamin reagent. The total amount of DNA in each transfection was adjusted to the same amount by addition of mock vector plasmid. The cells were washed with PBS and supplied with serum-free MEM. After 15 min of incubation, Lipofectamin-DNA mixtures were added into wells. The cells were transfected for 3 h with the plasmid, then washed twice with PBS and then grown in MEM supplemented with 10% FBS and 100 µg/ml antibiotics/antimycotics. After 48 h, the cells were harvested and lysed by 200 µl of reporter lysis buffer (Promega), and cell debris was removed by centrifugation. Luciferase activities were measured using 10 µl of cell extract and 50 µl Luciferase assay reagent (Promega). For β-galactosidase assay, the hydrolysis of Onitrophenol-β-D-galactopyranoside (Sigma Aldrich, St. Louis, MO) at 37 o C was measured at 420 nm (24) . Total proteins of lysates were determined by Bradford method. Luciferase activities were normalized by amount of total proteins because CMV promoter-driven expression of β-galactosidase is suppressed by overexpression of SREBP-1a.
Drosophila SL2 cells were grown in Schneider's insect media (Sigma Aldrich, St. Louis, MO) supplemented with 10% (v/v) fetal bovine serum and 1% penicillin/streptomycin at 25 °C without supplemental CO 2 . For transfection, cells were plated at a density of 5 X 10 5 cells/35-mm dish, and were co-transfected on the next day by calcium phosphate coprecipitation method.
The promoter-luciferase construct (0.4 µg) of phP-IIβ-93/+65 or mSp1 was co-transfected with 0.2 µg of expression plasmids, such as pPac_SPREP1a, pPac_SREBP1c, pPac_SP1, and/or pPac mock vector, together with 0. mM sodium pyrophosphate) with glass homogenizer and sonicated three times for 30 s on ice.
The homogenate was centrifuged to remove the cell debris, and protein concentration of the soluble fraction was determined with Bradford reagent. Extracts were separated in 5% SDSpolyacrylamide gel and transferred to Protran nitrocellulose membrane (Schleicher & Schuell).
Immunoblot analysis was carried out with polyclonal anti-ACCβ antibody or horse radish peroxidase-conjugated strepavidin, and specific bands were visualized using ECL Kit (Amersham).
RNase protection assays-The pCRII plasmids containing cDNA for exon 1a (90 bp) or exon 1b (52 bp) extending to the part of exon 2 (69 bp), were used as templates for cRNA synthesis.
After linearization of each plasmid (1 µg) by HindIII digestion, 32 P-labeled cRNA was synthesized by T7 RNA polymerase (Ambion, Austin, TX). Probes were purified by gel elution after 6 % polyacrylamide/6M urea gel electrophoresis. RNase protection assays with purified probes were performed with RPAIII kit. Total RNA (20 µg) isolated from rat liver was hybridized with probe (1. respectively. The cycle numbers of PCR was determined, where the amplifications of target DNA were dependent on the amounts of samples. PCR products were subjected to electrophoresis in a 2% agarose gel, and visualized by ethidium bromide staining.
RESULT

Dietary regulation of ACCβ expression in liver;
ACCβ is known to play a critical role in regulation of fatty acid β-oxidation in skeletal muscle and heart, where its product, malonyl-CoA regulates the uptake of fatty acid into mitochondria by modulating the CPT-I. Fatty acid oxidation rate in muscle is rapidly changed by regulating the phosphorylation levels of ACCβ in response to physical exercise (8) (9) (10) . In contrast, the fatty acid oxidation rate in liver is markedly, but slowly changed by nutritional status. This control in liver drives us to suppose that the activities of ACCβ might be mainly regulated by the enzyme contents rather than the phosphorylation levels. To check this possibility, we have determined hepatic ACCβ expression in protein level and mRNA level in fasted and refed rats. The administration of fat-free high-carbohydrate diet resulted in the induction of two streptavidin-reactive proteins of about 260 kDa in size by western blot analysis.
The size of these two bands corresponds to the expected size of ACC proteins, and these high molecular weight bands were undetectable in liver homogenates from rats fasted for 48 h (Fig. 1,   lane 1-3 ). ACC induction in rat liver is supposed to be specific, based on the fact that the levels of the other biotin-containing proteins, of which molecular sizes were below 200 kDa, were not changed by food intake. To clarify which of two bands is ACCβ, we carried out the same blot with the specific antibody against the NH 2 -terminus of ACCβ. The primary difference in amino acid sequences of ACCβ from ACCα is the additional NH 2 -terminal 200 amino acids in ACCβ, known as a probable mitochondrial targeting signal (3,4). As expected, only the upper band with higher molecular weight of the two was detected (Fig. 1, lane 4-6 ) by antibody against ACCβ.
These data demonstrated that the levels of ACCβ, for which phosphorylation/dephosphorylation has been the focus of the major mechanism of regulation, are markedly increased in liver by food intake as well as those of ACCα. To demonstrate whether this induction of ACCβ protein accompanies the increase of its mRNA in liver, Northern blot hybridization was carried out with the probe specific to ACCβ on the total RNA isolated from livers of rats treated as the same.
The ACCβ mRNA was significantly increased within 12 h after food intake, and was shown to be markedly increased at 24 h after refeeding. These results suggest that the expression of ACCβ is controlled at transcriptional level in liver.
5'-UTRs for ACCβ mRNA in liver and the responsiveness of ACCβ promoters to SREBP-1
Human ACCβ gene is known to be controlled by two kinds of promoter; P-I and P-II ( Fig. 2B ) (11) . To address which of these two promoters directs the expression of ACCβ gene in liver, we have analyzed the 5'-UTR of ACCβ transcripts from rat liver by RNase protection assays using cRNA probes covering parts of exon 1a (90 nucleotides), or exon 1b (52 nucleotides), which extend to exon 2 (69 nucleotides). Each probe is designated as probe I and probe II for exon 1a and exon 1b, respectively, as shown in Fig. 2A . The lengths of original probes were shown in reactions without adding RNase A/T1 mix ( Fig. 2A lane 1 and 8 ) and the complete digestion of probes in reactions without adding total RNA ( Fig. 2A lane 2 and 9 ). The protected fragments of both probes from digestion with RNase were markedly increased in refed rat livers, coinciding with the result of Northern blot analysis of ACCβ mRNA. The protected fragments of probe I appeared around 69 nucleotides in size corresponding to the exon 2 region of the probe ( Fig. 2A lane 3-6 ), while those of probe II showed 2 major bands around 120 nucleotides representing exon 1b-exon 2 ( Fig. 2A lane 10-13 ). These data suggest that promoter II mainly drives the expression of ACCβ in rat liver and is activated by food intake. Most lipogenic enzymes, such as fatty acid synthase, ATP citrate-lyase and ACCα, were induced in liver by the intake of fat-free high carbohydrate diet, and SREBP1c is reported to be a main mediator (16) (17) (18) . Thus, we have tested the effects to SREBP-1 on ACCβ promoters.
Overexpression of SREBP-1a markedly activated only promoter II of both human and rat ACCβ genes, but not promoter I (Fig. 2C) . These data suggests that promoter II is the principal promoter responsible for regulated expression of ACCβ by SREBP-1 in rat liver.
Localization of SREBP-1 responsive region in promoter II
To define the region mediating SREBP-1 responsiveness, the transient transfection assays were performed with serial deletion constructs of human ACCβ promoter II (Fig. 3) . 
Identification of SREBP-1 response elements in promoter II of ACCβ gene
For the purpose of identifying the SREBP-1 binding region in the human ACCβ promoter II, DNase I footprinting assay was performed (Fig. 4) . The region from -64 to -49 was protected from DNase I digestion by recombinant SREBP-1, strongly suggesting the binding of SREBP-1.
The region around the footprinted sequences is highly conserved between human and rat ( Fig.   5A ), and two potential elements for SREBP binding in human sequences, denoted as SRE1 (-62/-54) and SRE2 (-52/-44) are predicted by sequence analysis. In rat, SRE1 is highly conserved and three overlapping consensus sequences were predicted in SRE2 locus. For EMSA, the probes (-93/-21), containing wild and mutated sequences on SRE1 and/or SRE2 denoted in Fig. 5A , were generated by PCR with the same 32 P-labeled antisense primer (-40/-21) and cold sense primer (-93/-74) using ACCβ promoter-reporter constructs with/without mutations. Because the specific activities of all probes, including wild and mutant probes, were same, the differences in intensities between shifted bands in EMSA might be caused by differences in the affinities of SREBP-1 to probes. The probe, containing intact SRE1 and SRE2, formed a complex with SREBP-1, resulting in the single shifted band (Fig. 5B) . The mutation of SRE1 (mSRE1) severely decreased the SREBP-1 binding, but the mutation of SRE2 (mSRE2) slightly suppressed the complex formation with SREBP-1. The double mutation of SRE1 and SRE2 (mSRE1+2) almost completely inhibited the SREBP-1 binding. These findings indicate that SREBP-1 has the strong affinity to SRE1, and weak to SRE2.
The region from -73 to -68 (CCCTCC) in rat promoter matches perfectly with CT motif reported as binding site for Sp1 and Sp3 in a variety genes, such as ATP citrate-lyase, lipoprotein lipase, and LDL receptor genes (27) (28) (29) . In human sequence, this region (-71/-66) is also highly conserved except A to T nucleotide substitution. To address the binding of Sp1 to this promoter region, we carried out EMSA with the probe from -82 to -53 of human sequence.
This probe produced one major complex by incubation with rat liver nuclear extract, and the complex was supershifted by antibody against Sp1 (Fig. 5C ). The mutation of CCCACC to CCCAAA abolished the Sp1 binding (data not shown). These data suggest that this locus immediately upstream of SRE1 binds Sp1 in both human and rat promoters.
Next, we tested the effect of these mutations on SREBP-1-responsiveness of the promoter II (Fig. 6A) . The stimulation of promoter activity of phP-IIβ(-93/+65) by SREBP-1 was inhibited about 88% by the mutation in SRE1 (mSRE1). The mutation in SRE2 also resulted in marked inhibition (63%) of SREBP-1-mediated induction. The double mutation of SRE1 and SRE2 almost completely suppressed SREBP-1 activation. These data indicated that SRE1 and SRE2 play a critical role in SREBP-1-mediated induction of ACCβ promoter.
Interestingly, the mutation at Sp1 binding site markedly suppressed basal promoter activity and SREBP-1-mediated activation (Fig. 6A) , even though the deletion construct (phP-IIβ-38/+65) devoid of this region did not show any decrease of basal promoter activity (Fig. 3) . 
SREBP-1 binding in ACCβ promoter II was increased by refeeding high carbohydrate diet in vivo.
Finally, we have performed ChIP assay to observe whether SREBP-1 occupancy to ACCβ gene promoter II is actually influenced in rat livers by dietary status. The hepatic chromosomal DNA was cross-linked to the transcription factors binding to them by perfusion of DMEM containing formaldehyde into hepatic portal vein. Antibody specific to SREBP-1 was used to immunoprecipitate the fragmented chromatin, and then the specific portion of ACCβ gene was amplified by PCR (Fig. 7A) . The association of SREBP-1 to promoter I was not detectable in both fasted and refed state (Fig. 7C) . In refed group, the amounts of amplified promoter II sequence were increased proportionally to the amounts of chromatin DNA immunoprecipitated by anti-SREBP-1 until 33 cycles of PCR, whereas the amplifications were not detected in fasted group (Fig. 7B) . The amounts of input DNAs in all samples, which were used for immunoprecipitation, were almost the same, referring to similar patterns of amplification in both fasted and refed groups. These results indicate that the occupancy on proximal region of promoter II by SREBP-1 is drastically regulated in vivo by feeding status and this regulation might mediate the control of ACCβ gene expression in liver by diet.
Discussion
The sequence of N-terminal 20 amino acid residues of ACCβ is highly hydrophobic and has a role targeting ACCβ to outer membrane of mitochondria (4). The mitochondrial localization enables ACCβ to control malonyl-CoA concentration around mitochondria, which is the rate-limiting factor of mitochondrial fatty acid oxidation. The activity of ACCβ in muscle is rapidly changed by phosphorylation-dephosphorylation mechanism, but not by alteration of enzyme contents. Exercise (8,9,11), leptin (7) or adiponectin (30) increase phosphorylation levels of ACCβ by activating AMP-activated protein kinase. Phosphorylation of ACCβ leads to inhibition of its activity and thus decreases malonyl-CoA concentration around mitochondria.
As a result, the suppression of CPT-I is relieved and β-oxidation will be activated. Fatty acid oxidation in liver is controlled by nutritional status, not by exercise. Long-term fasting markedly increases the fatty acid mobilization from adipose tissue to liver, where fatty acids were oxidized to acetyl-CoA destined for ketone bodies. The ketone body production via oxidation of fatty acid in liver is supposed to be regulated by ACCβ, because knocking out the ACCβ in mice resulted in the exaggerated production of β-hydroxybutyrate (13). The animals lacking this enzyme showed decreased body weight in spite of increased food intake, probably due to the increase of basal metabolism, indicating that the regulation of ACCβ activities plays a critical role in maintaining energy homeostasis. In present study, we revealed that long-term fasting for 48 hours almost completely depleted the ACCβ in liver, whereas the food intake drastically increases the level of this enzyme. Induction of this enzyme in liver by dietary scheme occurs mainly at transcriptional level in a similar manner as the inductions of other lipogenic enzymes, such as ACCα, ACL, and FAS (31-33). These facts suggest that the increased basal metabolism due to lack of ACCβ might result in part from futile cycle of fatty acid synthesis and its oxidation during feeding state in liver as well as from the increased β-oxidation of fatty acid in Northern blot analysis. Total RNA (20 µg) isolated from livers of each group was subjected to 0.9% formaldehyde agarose gel electrophoresis. RNA in the gel was transferred to nylon membrane and hybridized to 32 P-labeled cDNAs for ACCβ or rat β-actin. B. EMSA of wild and mutant probes (-93/-21) using recombinant SREBP-1a. All probes were generated by PCR using same 32 P-labeled primer and purified from polyacrylamide gel slice after electrophoresis. The probes were incubated with 10 ng of recombinant SREBP-1. C. Sp1
binding to -82/-53 probe. The -82/-53 probe and the nuclear extracts (10 µg) prepared from rat liver were incubated in the presence of 0, 1, 2, or 3 µl of anti-Sp1 antiserum. 
